{"id":"W2033163507","doi":"10.1016/j.clinthera.2013.12.011","title":"Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation","year":2014,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Pfizer","keywords":"Apixaban; Medicine; Rivaroxaban; Dabigatran; Atrial fibrillation; Stroke (engine); Discontinuation; Cost effectiveness; Randomized controlled trial; Quality-adjusted life year; Warfarin; Quality of life (healthcare); Internal medicine; Intensive care medicine; Cardiology; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004925924,0.0006485104,0.001061622,0.0009572538,0.0002930039,0.001725689,0.0008883169,0.000920817,0.004219733],"category_scores_gemma":[0.0146385,0.0005221358,0.003158102,0.0007483984,0.0005504251,0.001675941,0.001056586,0.001175108,0.0001241031],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005286735,"about_ca_system_score_gemma":0.003545659,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007528011,"about_ca_topic_score_gemma":0.005373592,"domain_scores_codex":[0.9968471,0.002335609,0.0001436462,0.0001743245,0.0003040268,0.0001953053],"domain_scores_gemma":[0.9925117,0.005984338,0.0008379978,0.0001325301,0.0002258986,0.0003074348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.0154493,0.0008082247,0.08219916,0.001431012,0.007127567,0.0003821349,0.0001191283,0.8277173,0.0006669476,0.01545405,0.001674259,0.0469709],"study_design_scores_gemma":[0.006147502,0.00831945,0.06461134,0.001114081,0.009839006,0.001130235,0.0003595079,0.8772887,0.001259224,0.02584465,0.003936019,0.0001502728],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.960569,0.01211634,0.01138701,0.003632522,0.000173518,0.000682355,0.002966789,0.00006371584,0.008408684],"genre_scores_gemma":[0.996876,0.0009927137,0.001211111,0.0001393889,0.00001984861,0.000108662,0.0003468732,0.000004107541,0.0003014122],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007528011,"threshold_uncertainty_score":0.03835815,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4687215229406663,"score_gpt":0.5252876808651197,"score_spread":0.05656615792445335,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}